Litigation Details for HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Docket		Date Filed	2020-07-02
Court	District Court, D. New Jersey	Date Terminated	2021-12-15
Cause	35:271 Patent Infringement	Assigned To	Stanley R. Chesler
Jury Demand	Plaintiff	Referred To	Cathy L. Waldor
Patents	8,067,033; 8,067,451; 8,309,127; 8,318,202; 8,449,910; 8,501,228
Link to Docket	External link to docket

Details for HORIZON MEDICINES LLC v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-07-02	1	Complaint	United States Patent Nos. 8,067,033 (“the ’033 patent”), 8,067,451 (“the ’451 patent”), 8,309,127 (…910 and ’228 patents. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,067,033 … (“the ’127 patent”), 8,318,202 (“the ’202 patent”), 8,449,910 (“the ’910 patent”), and 8,501,228 (“…. This is an action for patent infringement arising under the patent laws of the United States,…(“the ’228 patent”) (collectively, the “Asserted Patents”), which cover DUEXIS® and its use.	External link to document
2021-05-05	83	Opinion	counterclaims relating to U.S. Patent No. 8,067,033 (“the ’033 patent”) pending resolution of Horizon…litigation regarding six patents related to the drug Duexis®. Plaintiff holds the patents and Defendant Teva…GRANTED; that all proceedings relating to the 033 patent in this case are hereby STAYED pending resolution…litigated a similar case, involving the same six patents and an ANDA to make a generic version of Duexis…inter alia: 1) claims 1, 8, 11, and 14 of the ’033 patent are invalid as obvious and not infringed; and	External link to document